A better path forward for cancer care

May 5, 2026

From the moment of diagnosis, UT Health San Antonio patients are connected to a system designed to expand their treatment possibilities and bring the full strength of medicine and research to their care. Specialized programs focus on common and rare cancers, which allows for more personalized treatment approaches. For those at increased risk, services such as cancer genetics counseling and risk-reduction clinics offer early insight and prevention strategies.

Two women sit at a table facing each other and talking.

UT San Antonio-led cancer research program could revolutionize treatment

April 23, 2026

Written by: Claire Kowalick More than 70% of cancers — including breast, bladder, cervical and lung cancer — show evidence of mutations linked to a group of enzymes called apolipoprotein B mRNA-editing enzyme catalytic polypeptides, or APOBEC. “APOBEC mutagenesis is the second-largest source of mutation in cancer and, importantly, the largest one we can do […]



New study aims to guide prostate cancer patients through early treatment decisions

April 13, 2026

  For more than 20 years, Lixin Song, PhD, RN, FAAN, vice dean for research and scholarship and professor of nursing at The University of Texas at San Antonio (UT San Antonio) School of Nursing, has studied how cancer patients and their families navigate the challenging experience of making decisions about treatment while facing uncertainty, […]

San Antonio Breast Cancer Symposium® fuels $39.6 million impact and advances in cancer care

March 31, 2026

Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Susan Anasagasti SAN ANTONIO, March 31, 2026 — The San Antonio Breast Cancer Symposium® drew more than 11,000 attendees to downtown San Antonio and generated nearly $40 million in economic impact, according to a new report from Visit San Antonio. Held each December at the Henry B. […]



Mays Cancer Center hosts national symposium on cancer drug development

March 12, 2026

National experts in cancer drug development gathered at a symposium hosted by the UT Health San Antonio Mays Cancer Center’s Experimental and Drug Therapeutics Program to discuss new strategies and opportunities in cancer research and tackle pressing challenges in patient care.